Seven years after publication of the third edition, this latest edition of Clinical Otology brings the reader right up to date with developments within this constantly evolving field. Maintaining the same format as the previous edition, it concentrates on four...
Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...
An admission on emissions from James Hall! OAEs hold an established place in the screening of infants; Professor Hall introduces how OAEs established this position and the advances keeping the test relevant to today’s infant screening battery. Introduction Truthfully, when...
Solar powered hearing aids In the middle of the morning of January 24, 2002, I had been in Otse for only three days, a village of 3500 in the south of Botswana, when I heard a knock at the door....
Should we be using new or novel objective measures and imaging to assist with our cochlear implant patients? Debi Vickers and Shak Saeed describe current clinical techniques and present advances that have the potential to optimise outcomes. Introduction It is...
True Cut is a stage play that asks: “What happens when things go wrong in healthcare?” It brings the hidden world of the operating theatre onto the theatre stage. ENT surgeon, David Alderson, talks about how the play came about....
Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...
1 May 2018
| David T Kemp, Ted Killan
|
ENTA - ENT
Ted Killan, Vice-Chair of the British Society of Audiology (BSA), caught up with Professor Kemp to discuss his scientific journey over the past 40 years, and what we can expect from OAEs in the future. Prof David T Kemp. In...
Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...
In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...
Myron Metzenbaum was born in Cleveland, Ohio (USA) in 1876, the fourth of nine children. As a young man, he worked in the family’s linen store, where his father was well known to be very kind to the less fortunate...
Dr Peter Belafsky. Peter – tell us about your background I was born in Philadelphia and went on to study at Vassar College which is a small liberal arts school in upstate New York. I then attended Medical School in...